MARCH 1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells

Membrane-associated RING-CH1 (MARCH1) is an E3 ubiquitin ligase that mediates ubiquitination of MHCII and CD86 in DCs (Matsuki et al., 2007; Baravalle et al., 2011). This ubiquitination induces MHCII and CD86 endocytosis, lysosomal transport, and degradation (Shin et al., 2006; van Niel et al., 2006; Baravalle et al., 2011). The functional role of MARCH1 has been studied mainly in the context of DC maturation and T cell activation or regulation in vitro. When DCs are exposed to maturation stimuli, MARCH1 is rapidly down-regulated (De Gassart et al., 2008; Walseng et al., 2010). This down-regulation leads to an increase in MHCII and CD86 on the DC surface, which enhances the ability of the cell to stimulate antigen-specific T cells (Baravalle et al., 2011). In contrast, when DCs are exposed to the immune suppressive cytokine IL-10, MARCH1 is up-regulated (Tze et al., 2011; Baravalle et al., 2011). This up-regulation results in a reduction of MHCII and CD86 surface levels, and diminishes the DC’s ability to activate T cells (Baravalle et al., 2011). These studies suggest that MARCH1 plays a regulatory role in T cell activation during immune responses. However, the role of MARCH1 at steady state or in vivo is not well understood although a recent study has suggested that MARCH1 might be involved in splenic DC homeostasis (OhmuraHoshino et al., 2009). At steady state, MHCII plays an important role in CD4 T cell development in the thymus (Laufer et al., 1996). Furthermore, MHCII critically impacts the development of natural regulatory T cells (T reg cells), a unique CD4 T cell subset equipped with potent immune suppressive capacity (Hsieh et al., 2012). Co-stimulatory molecules, including CD86, also mediate T reg cell and NKT cell development (Salomon et al., 2000; Williams et al., 2008). Thus, given the function of MARCH1 in controlling MHCII CORRESPONDENCE Jeoung-Sook Shin: jeoung-sook.shin@ucsf.edu

[1]  N. Mukaida,et al.  Novel Process of Intrathymic Tumor-Immune Tolerance through CCR2-Mediated Recruitment of Sirpα+ Dendritic Cells: A Murine Model , 2012, PloS one.

[2]  C. Hsieh,et al.  Selection of regulatory T cells in the thymus , 2012, Nature Reviews Immunology.

[3]  S. Ishido,et al.  Ubiquitination of CD86 Is a Key Mechanism in Regulating Antigen Presentation by Dendritic Cells , 2011, The Journal of Immunology.

[4]  E. Unanue,et al.  Functional Redundancy between Thymic CD8α+ and Sirpα+ Conventional Dendritic Cells in Presentation of Blood-Derived Lysozyme by MHC Class II Proteins , 2011, The Journal of Immunology.

[5]  C. Goodnow,et al.  CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation , 2011, The Journal of experimental medicine.

[6]  L. Klein,et al.  Regulatory T‐cell differentiation versus clonal deletion of autoreactive thymocytes , 2011, Immunology and cell biology.

[7]  A. Sher,et al.  Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus* , 2010, Journal of Biological Chemistry.

[8]  D. Voehringer,et al.  Autonomous role of medullary thymic epithelial cells in central CD4+ T cell tolerance , 2010, Nature Immunology.

[9]  E. Unanue,et al.  Thymus-Blood Protein Interactions Are Highly Effective in Negative Selection and Regulatory T Cell Induction1 , 2009, The Journal of Immunology.

[10]  O. Ohara,et al.  Cutting Edge: Requirement of MARCH-I-Mediated MHC II Ubiquitination for the Maintenance of Conventional Dendritic Cells1 , 2009, The Journal of Immunology.

[11]  N. Mukaida,et al.  Crucial Contribution of Thymic Sirpα+ Conventional Dendritic Cells to Central Tolerance against Blood-Borne Antigens in a CCR2-Dependent Manner , 2009, The Journal of Immunology.

[12]  W. Telford,et al.  Single Cell Analysis of Complex Thymus Stromal Cell Populations: Rapid Thymic Epithelia Preparation Characterizes Radiation Injury , 2009, Clinical and translational science.

[13]  B. Kyewski,et al.  The thymic medulla: a unique microenvironment for intercellular self-antigen transfer , 2009, The Journal of experimental medicine.

[14]  A. D'amico,et al.  Dendritic cells in the thymus contribute to T-regulatory cell induction , 2008, Proceedings of the National Academy of Sciences.

[15]  P. Naquet,et al.  Intercellular MHC transfer between thymic epithelial and dendritic cells , 2008, European journal of immunology.

[16]  S. Steinberg,et al.  Regulation of Thymic NKT Cell Development by the B7-CD28 Costimulatory Pathway , 2008, The Journal of Immunology.

[17]  Nadia Catalan,et al.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation , 2008, Proceedings of the National Academy of Sciences.

[18]  T. Chatila,et al.  Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen1 , 2007, The Journal of Immunology.

[19]  O. Ohara,et al.  Novel regulation of MHC class II function in B cells , 2007, The EMBO journal.

[20]  C. Melief,et al.  Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. , 2006, Immunity.

[21]  I. Mellman,et al.  Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination , 2006, Nature.

[22]  N. Copeland,et al.  Zfp423 Is Required for Normal Cerebellar Development , 2006, Molecular and Cellular Biology.

[23]  Nancy A. Jenkins,et al.  Simple and highly efficient BAC recombineering using galK selection , 2005, Nucleic acids research.

[24]  Michael J. Bevan,et al.  Central Tolerance to Tissue-specific Antigens Mediated by Direct and Indirect Antigen Presentation , 2004, The Journal of experimental medicine.

[25]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[26]  L. Glimcher,et al.  Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex , 1996, Nature.

[27]  J. Miller,et al.  Constitutive class I-restricted exogenous presentation of self antigens in vivo , 1996, The Journal of experimental medicine.

[28]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.